Requirement of tumor-associated antigen-specific CD4+ T cells for an efficient dendritic cell vaccine in antitumor immunotherapy

被引:0
作者
Simon, Thomas [1 ,2 ]
Fonteneau, Jean-Francois [2 ,3 ,4 ]
Gregoire, Marc [2 ,3 ,4 ]
机构
[1] INSERM, UMR1064, F-44000 Paris, France
[2] Univ Nantes, F-44000 Nantes, France
[3] Univ Nantes, Inst Rech Therapeut, INSERM, UMR892, F-44007 Nantes 1, France
[4] CNRS, UMR6299, F-4400 Nantes, France
关键词
antitumor immunotherapy; cytotoxic T cell; dendritic cells; helper T cell; melanoma; tumor-associated antigen; RESPONSES; MELANOMA; HELPER; PEPTIDE; LYMPHOCYTES;
D O I
10.2217/IMT.13.45
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evaluation of: Aarntzen EH, De Vries IJ, Lesterhuis WJ et al. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination. Cancer Res. 73(1), 19-29 (2012). The induction of antitumor immune responses in patients is one of the most sought-after goals in cancer treatment. The proposed clinical approach is to use autologous mature dendritic cells (DCs) loaded with class I peptides from tumor-associated antigens (TAAs), as DCs are the most efficient immune cells to generate strong and specific cytotoxic CD8(+) T-lymphocyte (CTL) responses. To optimize DC-based cancer vaccines, Aarntzen et al. evaluated the necessity to stimulate TAA-specific CD4(+) T-helper cells to reinforce antitumor CTL responses. They demonstrated that intranodal injection of DCs pulsed with class I-and II-restricted TAA epitopes increases TAA-specific CTL responses and induces better clinical responses in stage III/IV melanoma patients than the use of DCs pulsed with class I-restricted TAA epitopes alone. This study highlights the interest of concomitant stimulation of TAA-specific CD4(+) and CD8(+) T cells for DC-based antitumor immunotherapy.
引用
收藏
页码:565 / 567
页数:3
相关论文
共 17 条
[1]   Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination [J].
Aarntzen, Erik H. J. G. ;
De Vries, I. Jolanda M. ;
Lesterhuis, W. Joost ;
Schuurhuis, Danita ;
Jacobs, Joannes F. M. ;
Bol, Kalijn ;
Schreibelt, Gerty ;
Mus, Roel ;
De Wilt, Johannes H. W. ;
Haanen, John B. A. G. ;
Schadendorf, Dirk ;
Croockewit, Alexandra ;
Blokx, Willeke A. M. ;
Van Rossum, Michelle M. ;
Kwok, William W. ;
Adema, Gosse J. ;
Punt, Cornelis J. A. ;
Figdor, Carl G. .
CANCER RESEARCH, 2013, 73 (01) :19-29
[2]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[3]   INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE [J].
FEARON, ER ;
PARDOLL, DM ;
ITAYA, T ;
GOLUMBEK, P ;
LEVITSKY, HI ;
SIMONS, JW ;
KARASUYAMA, H ;
VOGELSTEIN, B ;
FROST, P .
CELL, 1990, 60 (03) :397-403
[4]   Immunology - Licence to kill [J].
Lanzavecchia, A .
NATURE, 1998, 393 (6684) :413-414
[5]   A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+T lymphocytes [J].
Larrieu, Pierre ;
Ouisse, Laure-Helene ;
Guilloux, Yannick ;
Jotereau, Francine ;
Fonteneau, Jean-Francois .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (10) :1565-1575
[6]   Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells [J].
Nestle, FO ;
Alijagic, S ;
Gilliet, M ;
Sun, YS ;
Grabbe, S ;
Dummer, R ;
Burg, G ;
Schadendorf, D .
NATURE MEDICINE, 1998, 4 (03) :328-332
[7]   Cancer immunotherapy via dendritic cells [J].
Palucka, Karolina ;
Banchereau, Jacques .
NATURE REVIEWS CANCER, 2012, 12 (04) :265-277
[8]   The role of CD4+ T cell responses in antitumor immunity [J].
Pardoll, DM ;
Topalian, SL .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) :588-594
[9]   A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell [J].
Ridge, JP ;
Di Rosa, F ;
Matzinger, P .
NATURE, 1998, 393 (6684) :474-478
[10]   T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions [J].
Schoenberger, SP ;
Toes, REM ;
van der Voort, EIH ;
Offringa, R ;
Melief, CJM .
NATURE, 1998, 393 (6684) :480-483